Migdal Insurance & Financial Holdings’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $192K | Sell |
2,780
-340,609
| -99% | -$23.5M | ﹤0.01% | 212 |
|
|
2025
Q1 | $24.2M | Buy |
343,389
+339,820
| +9,521% | +$24M | 0.34% | 52 |
|
|
2024
Q4 | $307K | Sell |
3,569
-1,800
| -34% | -$155K | ﹤0.01% | 192 |
|
|
2024
Q3 | $640K | Sell |
5,369
-2,709
| -34% | -$323K | 0.01% | 165 |
|
|
2024
Q2 | $1.16M | Sell |
8,078
-183
| -2% | -$26.2K | 0.02% | 146 |
|
|
2024
Q1 | $1.06M | Sell |
8,261
-185
| -2% | -$23.8K | 0.02% | 143 |
|
|
2023
Q4 | $874K | Buy |
8,446
+1,300
| +18% | +$135K | 0.02% | 174 |
|
|
2023
Q3 | $651K | Buy |
+7,146
| New | +$651K | 0.01% | 176 |
|